CDA | Evidence Driven
CDA | Evidence Driven

Somatropin for Short Stature Secondary to Small for Gestational Age

Details

Files
Project Status:
Completed
Project Line:
Reference List
Project Sub Line:
Summary of Abstracts
Project Number:
RB1669-000
Effective finish date:

Question

  1. What are the evidence-based guidelines regarding the use of growth hormone therapy for children with short stature secondary to small for gestational age?

Key Message

We identified 1 evidence-based guideline about the use of growth hormone therapy for children with short stature secondary to small for gestational age.

Files

Somatropin for Short Stature Secondary to Small for Gestational Age View PDF
Last Updated : June 27, 2023